DIA
Drug Information Association Logo

The Regulatory Development of a Drug

| Online

« Back to Listing

Overview 

This course, a Thomson Reuters Cortellis Regulatory Online Learning module, describes the overall drug development process in detail. It discusses the importance of a global development program and of a regulatory strategy for obtaining and maintaining drug marketing authorizations. The course outlines the roles and responsibilities of regulatory affairs professionals. It concludes by demonstrating that regulatory and competitive intelligence are indispensable tools for strategic decision-making.

Featured Topics 

  • Drug development process
  • Global drug development
  • Regulatory strategy for obtaining and maintaining drug marketing authorizations

Who Should Attend 

Professionals and experts in the pharmaceutical, biotechnology, and medical device fields

Learning Objectives 

Participants who complete this course should be able to:

  • Identify the studies involved in the drug development process
  • Explain the objectives of the four phases of clinical studies
  • Identify the major issues encountered by the pharmaceutical industry today
  • Understand the importance of a global development programme and a regulatory strategy
  • Describe the purpose of Regulatory Affairs
  • Explain the roles and responsibilities of a Regulatory Affairs professional
  • Identify the main resources for regulatory and competitive intelligence

The course takes an average of one hour to complete.

Contact Information 

Linda Belmont, DIA
Phone +1.215.293.5818
Linda.Belmont@diahome.org

Technical Requirements 

Click here for minimum system requirements.

Registration Fees 

Other Fees

Individual
$360.00
Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top